RLMD - Relmada Therapeutics Inc. (RLMD) Q4 2023 Earnings Call Transcript

2024-03-19 19:08:05 ET

Relmada Therapeutics, Inc. (RLMD)

Q4 2023 Earnings Conference Call

March 19, 2024, 04:30 PM ET

Company Participants

Tim McCarthy - IR, Advisors

Sergio Traversa - CEO

Maged Shenouda - CFO

Conference Call Participants

Basma Radwan - Leerink Partners

Uy Ear - Mizuho

Andrew Tsai - Jefferies

Andrea Tan - Goldman Sachs

Presentation

Operator

Good afternoon, ladies and gentlemen, and welcome to the Relmada Therapeutics Inc. Fourth Quarter and Full Year 2023 Results Call. At this time, all lines are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions] This call is being recorded on Tuesday, March 19, 2024.

I would now like to turn the conference over to Mr. Tim McCarthy. Thank you. Please go ahead.

Tim McCarthy

Thank you, operator, and thank you all for joining us this afternoon. With me on today's call are Chief Executive Officer, Sergio Traversa and Chief Financial Officer, Maged Shenouda. This afternoon, Relmada issued a press release, providing a business update, announcing financial results, for the three and 12 months ended December 31, 2023.

Please note that certain information discussed on the call today, is covered under the Safe Harbor provisions, of the Private Securities Litigation Reform Act. We caution listeners that during this call, Relmada's management team will be making forward-looking statements. Actual results could differ materially, from those stated, or implied by these forward-looking statements, due to risks and uncertainties associated with the company's business....

For further details see: